| 注册
首页|期刊导航|临床误诊误治|ADAM17-HMGCS1轴促进结直肠癌的分子机制研究

ADAM17-HMGCS1轴促进结直肠癌的分子机制研究

王寅格 张哲恺 李洁 赵会懂 李丹秀 靳海峰 杨桃

临床误诊误治2025,Vol.38Issue(19):47-55,9.
临床误诊误治2025,Vol.38Issue(19):47-55,9.DOI:10.3969/j.issn.1002-3429.2025.19.008

ADAM17-HMGCS1轴促进结直肠癌的分子机制研究

Molecular mechanism of ADAM17-HMGCS1 axis promoting colorectal cancer

王寅格 1张哲恺 2李洁 3赵会懂 4李丹秀 5靳海峰 5杨桃6

作者信息

  • 1. 河北工程大学临床医学院,河北 邯郸 072350
  • 2. 解放军联勤保障部队第九八〇医院卫勤部,石家庄 050082
  • 3. 空军第九八六医院普通外科,西安 710000
  • 4. 解放军联勤保障部队第九八〇医院医学信息数据室,石家庄 050082
  • 5. 解放军联勤保障部队第九八〇医院消化内科,石家庄 050082
  • 6. 贵州中医药大学第一附属医院肛肠科,贵阳 550001
  • 折叠

摘要

Abstract

Objective To investigate the molecular mechanism of A disintegrin and metalloproteinase 17(ADAM17)-3-hydroxy-3-methylglutaryl-coa synthase 1(HMGCS1)axis in promoting colorectal cancer(CRC).Methods The expression of ADAM17 in CRC was analyzed by the cancer genome map database,and the impact of ADAM17 on prognosis was analyzed by Kaplan-Meier survival.The shADAM17 stable knockdown cell line was constructed by selecting the CR HUTU80 cell line with high expression of ADAM17,and the ADAM17 overexpression cell line was constructed by using the SW620 cell line with low expression of ADAM17.The in vitro proliferation ability of cells was analyzed through experiments such as CCK-8,plate cloning and cell immunofluorescence detection of proliferating cell nuclear antigen.A subcutaneous transplanted tumor model in nude mice was constructed to evaluate tumorigenicity in vivo.Key differential genes and pathways were screened by transcriptome sequencing,and the molecular regulatory relationships were verified by real-time fluorescence quantitative PCR(RT-qPCR)and Western blot.Results Database analysis indicated that ADAM17 was highly expressed in CRC and was positively correlated with poor prognosis(P<0.05).ADAM17 was highly expressed in HUTU80 cells but lowly expressed in SW620 cells(P<0.05).Knockdown of ADAM17 could significantly inhibit the proliferation of HUTU80 cells,while overexpression of ADAM17 promoted the proliferation of SW620 cells(P<0.05).Subcutaneous transplanted tumor models in nude mice confirmed that knockdown of ADAM17 could inhibit tumor volume and tumor mass(P<0.05).Transcriptome sequencing showed that knockdown of ADAM17 would lead to down-regulation of HMGCS1 expression(P<0.05),and further analysis revealed that lipid metabolism pathways were significantly enriched after ADAM17 knockdown.Western blot and RT-qPCR verified that the protein and mRNA expression of HMGCS1 was positively correlated with ADAM17(P<0.05).Conclusion ADAM17 can drive the proliferation of CRC cells by positively regulating HMGCS1 expression and plays an important role in lipid metabolism pathways.The potential role of the ADAM17-HMGCS1 axis in CRC can provide a new research direction for future targeted therapy,and further verifying the effectiveness of its clinical application will be of great significance.

关键词

结直肠癌/去整合素-金属蛋白酶17/3-羟基-3-甲基戊二酰辅酶A合酶1/脂代谢/细胞增殖/预后

Key words

colorectal cancer/a disintegrin and metalloproteinase 17/3-hydroxy-3-methylglutaryl-CoA synthase 1/lipid metabolism/cell proliferation/prognosis

引用本文复制引用

王寅格,张哲恺,李洁,赵会懂,李丹秀,靳海峰,杨桃..ADAM17-HMGCS1轴促进结直肠癌的分子机制研究[J].临床误诊误治,2025,38(19):47-55,9.

基金项目

国家中医药管理局高水平中医药重点学科建设基金资助项目(zyyzdxk-2023188) (zyyzdxk-2023188)

河北省医学科学研究课题计划资助项目(20231296) (20231296)

贵州中医药大学国家与省级科技创新人才团队培育基金资助项目(贵中医TD合字[2022]005) (贵中医TD合字[2022]005)

河北省自然科学基金资助项目(H2023505002) (H2023505002)

临床误诊误治

1002-3429

访问量0
|
下载量0
段落导航相关论文